ArcherDX Announces Partnership with Illumina to Develop In-Vitro Diagnostic Tests
By: Colorado BioScience Association Date: 12/04/2019
ArcherDX, Inc., a growth-stage molecular diagnostics company dedicated to developing breakthrough solutions that advance personalized genomic medicine, today announced a non-exclusive partnership with...
Learn More$5.2 Million Advanced Industries Awards in Fall 2019 Will Fuel 24 Colorado Start-ups
By: Colorado BioScience Association Date: 11/22/2019
A Colorado company with the transformative technology behind a revolutionary prosthetic socket design that provides easier application and release was among 24 Colorado start-ups approved for funding...
Learn MoreSecurisyn Medical Awarded Fourth Air Force Contract for Innovation
By: Colorado BioScience Association Date: 11/13/2019
Securisyn Medical, LLC, dedicated to inspiring the world to collaborate to make airway management safer, announced today that the United States Air Force (USAF) has awarded the Company a $750,000 Smal...
Learn MoreAMPIO PROVIDES UPDATE ON CONTINUED PROGRESS OF AP-013 PHASE III CLINICAL TRIAL AND MANUFACTURING FACILITY
By: Colorado BioScience Association Date: 11/12/2019
Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) a development stage biopharmaceutical company, executing a Special Protocol Assessment (SPA) Phase III clinical trial titled “Evaluating the Efficacy...
Learn MoreBiodesix Appoints Scott Hutton as Chief Executive Officer
By: Colorado BioScience Association Date: 11/05/2019
Biodesix, Inc., the leader in lung cancer diagnostic solutions, today announced that current Chief Operating Officer Scott Hutton will become Chief Executive Officer on January 1, 2020. Current CEO Da...
Learn MoreIM Therapeutics Is Developing A Novel Targeted Therapy Pipeline in Autoimmune Disease
By: Colorado BioScience Association Date: 10/28/2019
Type 1 Diabetes Therapy Being Readied for Clinical Trials; Celiac Disease in Drug Development Autoimmune diseases affect about 4% of the world’s population and comprise over 80 disorders, many of whic...
Learn MoreSomaLogic significantly expands key strategic collaboration with Novartis
By: Colorado BioScience Association Date: 10/23/2019
Ten-year agreement with Novartis demonstrates broad and deep commitment to accelerating disease and therapeutic-specific insights based on proprietary proteomic technology Boulder, Colo., USA — SomaLo...
Learn MoreRegulatory Affairs Professionals Society (RAPS) Welcomes New RAPS Colorado Chapter
By: Colorado BioScience Association Date: 10/17/2019
Rockville, MD, USA, Oct. 17, 2019 (GLOBE NEWSWIRE) The Regulatory Affairs Professionals Society (RAPS) announced the official launch of the RAPS Colorado Chapter. The group first began as a RAPS...
Learn MoreSecurisyn Medical Receives FDA 510(k) Clearance for its SolidAIRity™ III Airway Stabilization System
By: Colorado BioScience Association Date: 10/14/2019
HIGHLANDS RANCH – October 9, 2019 – Securisyn Medical, LLC, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (“FDA”) to market its SolidAIRity™ III Airw...
Learn MoreIM Therapeutics Raises $10 Million Financing Co-Led by JDRF T1D Fund and Morningside Ventures
By: Colorado BioScience Association Date: 10/09/2019
IM Therapeutics Raises $10 Million Financing Co-Led by JDRF T1D Fund and Morningside Ventures Funding will Advance Lead Drug in Type 1 Diabetes and Develop HLA-Targeted Therapeutic Platform in Autoimm...
Learn More